Efficacy of COVID-19 Oral antivirals in hospitalised oldest-old with high morbidity burden: a target trial emulation study.

Francisco Tsz Tsun LaiBoyuan WangCuiling WeiCeline Sze Ling ChuiXue LiChing Lung CheungIan Chi Kei Ck WongEsther Wai Yin ChanEric Yuk Fai Wan

Published in: Age and ageing (2024)

Molnupiravir and nirmatrelvir-ritonavir are moderately effective in reducing mortality risk among hospitalised oldest-old patients with COVID-19, regardless of their vaccination status.

Keyphrases

coronavirus disease
sars cov
clinical trial
study protocol
phase ii
respiratory syndrome coronavirus